• 1
    Stewart WF, Lipton RB, Celentano DD, Reed M.. Prevalence of migraine headache in the United States. Relation to age, income, race, and other socio-demographic factors. JAMA 1992; 267: 649.
  • 2
    Lane PL, McLellan BA, Baggoley CJ. Comparative efficacy of CPZ and meperidine with dimenhydrinate in migraine headache. Ann Emerg Med 1989; 18: 3605.
  • 3
    Bell R., Montoya D., Shuaib A., Lee MA. A comparative trial of three agents in the treatment of acute migraine headache. Ann Emerg Med 1990; 19: 107982.
  • 4
    Cameron JD, Lane PL, Speechley M.. Intravenous chlor-promazine vs intravenous metoclopramide in acute migraine headache. Acad Emerg Med 1995; 2: 597602.
  • 5
    Stiell IG, Dufour D., Moher D., Yen M., Beilby WJ, Smith NA. Methotrimeprazine versus meperidine and dimenhydrinate in the treatment of severe migraine: a randomized, controlled trial. Ann Emerg Med 1991; 20: 12015.
  • 6
    Tek D., McClellan D., Olshaker M., Allen CL, Arthur DC. A prospective double-blind study of metoclopramide hydrochloride for the control of migraine in the emergency department. Ann Emerg Med 1990; 19: 10837.
  • 7
    Coppola M., Yealy DM, Leibold RA. A randomized, placebo-controlled evaluation of prochlorperazine versus metoclopramide for the emergency department treatment of migraine headache. Ann Emerg Med 1995; 26: 5416.
  • 8
    Saadah HA. Abortive migraine therapy in the office with intravenous dihydroergotamine and prochlorperazine. Headache 1992; 32: 1436.
  • 9
    Saadah HA. Abortive migraine therapy in the office with dexamethasone and prochlorperazine. Headache 1994; 34: 36670.
  • 10
    Fisher H.. A new approach to emergency department therapy of migraine headache with intravenous haloperidol: a case series. J Emerg Med 1995; 13: 11922.
  • 11
    Winner P., Ricalde O., Le Force B., Saper J., Margul B.. A double-blind study of subcutaneous dihydroergotamine vs. subcutaneous sumatriptan in the treatment of acute migraine. Arch Neurol 1996; 53: 1804.
  • 12
    Touchon J., Bertin L., Pilgrim AJ, Ashford E., Bes A.. A comparison of subcutaneous sumatriptan and dihydroergotamine nasal spray in the acute treatment of migraine. Neurology 1996; 47: 3615.
  • 13
    Ensink F-BM. Subcutaneous sumatriptan in the acute treatment of migraine. Neurology 1991; 238.S66S69.
  • 14
    Cady RK, Wendt JK, Kirchner JR, Sargent JD, Rothrock JF, Skaggs H.. Treatment of acute migraine with subcutaneous sumatriptan. JAMA 1991; 265: 28315.
  • 15
    The Multinational Oral Sumatriptan and Cafergot Comparative Study Group. A randomized, double-blind comparison of sumatriptan and Cafergot in the acute treatment of migraine. Eur Neurol. 1991;31:31422.
  • 16
    The Subcutaneous Sumatriptan International Study Group. Treatment of migraine attacks with sumatriptan. N Engl J Med. 1991;325:31621.
  • 17
    Akpunonu BE, Mutgi AB, Federman DJ, et al. Subcutaneous sumatriptan for treatment of acute migraine in patients admitted to the emergency department: a multicenter study. Ann Emerg Med 1995; 25: 4649.
  • 18
    Larkin GL, Prescott JE. A randomized, double-blind, comparative study of the efficacy of ketorolac tromethamine versus meperidine in the treatment of severe migraine. Ann Emerg Med 1992; 21: 91924.
  • 19
    Belgrade MJ, Ling LJ, Schleevogt MB, Ettinger MG, Ruiz E.. Comparison of single dose meperidine, butorphanol and di-hydroergotamine ir the treatment of vascular headache. Neurology 1989; 39: 5902.
  • 20
    Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia. 1988;8:51928.
  • 21
    Pryse-Phillips WEM, Dodick DW, Edmeads JG, et al. Guidelines for the diagnosis and management of migraine in clinical practice. Can Med Assoc J 1997; 156: 127387.
  • 22
    Price DD, Bush FM, Long S., Harkins SW. A comparison of pain measurement characteristics of mechanical visual analogue and simple numerical rating scales. Pain 1994; 56: 21726.